Feedback / Questions
N,N-dimethyltryptamine (AP-188) - Algernon Pharma
https://www.globenewswire.com/news-release/2023/06/05/2681818/0/en/Algernon-NeuroScience-Announces-Successful-Completion-of-Highest-Planned-Single-Dose-in-DMT-Phase-1-Trial-Accelerates-Plans-for-Phase-2-Stroke-and-TBI-Studies.html
Jun 5, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next